Related Experiment Video
Updated: May 14, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Imaging of neuroendocrine tumors
David Leung1, Lawrence Schwartz
1Department of Radiology, Columbia University, New York, NY 10032, USA.
Abstract:
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that differ in their biological, chemical, and physical behaviors depending on the degree of differentiation and locations. Consequently, evaluation of these tumors is complex, requiring clinical history, physical examination, laboratory data, and imaging. With advances in morphologic and functional imaging techniques, we now have tools for caring of patients with these tumors at diagnosis, staging, treatment assessment, and prognosis prediction. In general, no single imaging modality can provide all the necessary information. However, well-chosen combinations of available imaging modalities based on the indications, strength and limitations of the modalities, and local expertise will provide optimal evaluation of patients with NETs.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging
